Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Cole

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Journal of Neuro-Oncology|April 2, 1998
Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC)L D Recht, M J Glantz, P Meitner, et al.
The Prostate|February 11, 1999
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of CancerI Rosendahl, G M Kiebert, D Curran, et al.
Seminars in Oncology|December 1, 1996
Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and responseM J Glantz, H Choy, W Akerley, et al.
The New England Journal of Medicine|March 17, 1994
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials GroupW R Lenderking, R D Gelber, D J Cotton, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
Cancer|February 26, 1998
Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative resultsM J Glantz, B F Cole, L K Glantz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?M J Glantz, B F Cole, L Recht, et al.
Cancer Practice|March 20, 2002
Delirium in patients with cancer at the end of lifeJ L Cobb, M J Glantz, P K Nicholas, et al.
The Journal of Bone and Joint Surgery. American Volume|February 1, 1995
Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1K D Nord, D D Dore, V F Deeney, et al.
Cancer|June 15, 1995
Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow statusM J Glantz, W A Hall, B F Cole, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|April 2, 1998
Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC)L D Recht, M J Glantz, P Meitner, et al.
The Prostate|February 11, 1999
Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of CancerI Rosendahl, G M Kiebert, D Curran, et al.
Seminars in Oncology|December 1, 1996
Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and responseM J Glantz, H Choy, W Akerley, et al.
The New England Journal of Medicine|March 17, 1994
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials GroupW R Lenderking, R D Gelber, D J Cotton, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
Cancer|February 26, 1998
Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative resultsM J Glantz, B F Cole, L K Glantz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?M J Glantz, B F Cole, L Recht, et al.
Cancer Practice|March 20, 2002
Delirium in patients with cancer at the end of lifeJ L Cobb, M J Glantz, P K Nicholas, et al.
The Journal of Bone and Joint Surgery. American Volume|February 1, 1995
Evaluation of treatment modalities for septic arthritis with histological grading and analysis of levels of uronic acid, neutral protease, and interleukin-1K D Nord, D D Dore, V F Deeney, et al.
Cancer|June 15, 1995
Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow statusM J Glantz, W A Hall, B F Cole, et al.
Pageof 6